Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of “engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
The investigation also highlights the companies' failure to adequately protect users, particularly children and teenagers.
Last month, the Federal Trade Commission (FTC) and U.S. Department of Justice (DOJ) jointly hosted a public meeting of the interagency “Strike ...
California courts were home to the most federal trade secrets litigation over the past three years, according to a report ...
On Monday, fashion icon Michael Kors testified in an antitrust trial in Manhattan as a Federal Trade Commission lawsuit filed ...
Closing arguments have begun in the Federal Trade Commission's attempt to block the proposed merger of supermarket chains ...
Sometimes you’ll be the hottest thing on the block,” he said. “Sometimes you’ll be lukewarm. Sometimes you’ll be cold.” ...
More than a year ago, Buckeye Lake resident Pam Spring called Better Call 4 after she bought a pair of shoes from HeyDude.com ...
Under the FOCAL plan, federal agencies have been urged to prioritize asset management, vulnerability management, defensible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback